SCHEMBL24433103

SCHEMBL24433103

c1ccc(-c2nc3ccccc3nc2-c2cccc(-c3cccc(-c4c5ccccc5c(-c5cccnc5)c5ccccc45)c3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.47
F2 P00734 1/20 0.44
HPGD P15428 1/20 0.44
CYP1A2 P05177 3/20 0.43
CYP3A4 P08684 3/20 0.43
CLK4 Q9HAZ1 3/20 0.43
ALDH1A1 P00352 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2D6 P10635 2/20 0.43
TSHR P16473 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C19 P33261 1/20 0.43
HSD17B10 Q99714 1/20 0.43
GLA P06280 1/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 3/20 0.43
GAA P10253 2/20 0.43
DHODH Q02127 1/20 0.42
CYP2A6 P11509 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24433153 0.99 CYP11B1 (0.48) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL24433111 0.93 CYP11B1 (0.48) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL24433146 0.93 CYP11B1 (0.46) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL23608076 0.91 CYP11B1 (0.47) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL24433101 0.90 CYP11B1 (0.51) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL24433104 0.90 CYP11B1 (0.46) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL22470522 0.88 LMNA (0.49) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL29412315 0.88 LMNA (0.49) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL24433247 0.88 HPGD (0.48) CYP11B1F2HPGDCYP1A2CYP3A4
SCHEMBL13820013 0.88 CYP11B1 (0.53) CYP11B1HPGDCYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220158100-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220158100-A1 Organic Compound, Light-Emitting Device, Light-Emitting Apparatus, Electronic Device, and Lighting Device NQO1, CYP1A1, CYBA CYP11B1 585/4885F2 799/4885HPGD 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.